Discover MacuMira, a clinically proven technology approved by Health Canada. It uses a device that delivers microcurrent through closed eyes to target retinal cells and slow the progression of dry macular degeneration.
It’s for me if…
I have early to intermediate age-related dry macular degeneration.
Contraindications
This treatment should be avoided if you have a pacemaker, a cochlear implant, or if you suffer from severe or uncontrolled glaucoma, multiple sclerosis, or epilepsy.
Initial duration
4 sessions of 32 minutes for the first 10 days.
Cost
500 $ per session.
MacuMira is the only treatment currently available on the market for dry macular degeneration. This pain-free technology aims to slow the progression of the condition by acting directly on the cells of the retina to stimulate their regeneration.
Microcurrent stimulation sends pulses through closed eyelids, cleansing the retina and improving visual function in patients with dry macular degeneration.
Regain clearer vision and don’t let symptoms affect your quality of life. Make an appointment with one of our professionals today and discover MacuMira technology.
